As noted above with breast cancer, three studies on cancer risks in PTEN mutation carriers have projected an increased lifetime risk of endometrial cancer ranging from 19 to 28% at age 70, but each suffers from ascertainment bias [22,30,31]. The gene discussed is PTEN; the disease is endometrial cancer.